A5060876737- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- Cardiac Valve Diseases and Treatments
- Cardiac Imaging and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Peripheral Artery Disease Management
- Cerebrovascular and Carotid Artery Diseases
- Atrial Fibrillation Management and Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Aortic aneurysm repair treatments
- Cardiac and Coronary Surgery Techniques
- Colorectal Cancer Treatments and Studies
- Corporate Finance and Governance
- Heart Failure Treatment and Management
- Hepatocellular Carcinoma Treatment and Prognosis
- Complementary and Alternative Medicine Studies
- Psoriasis: Treatment and Pathogenesis
- Advancements in Photolithography Techniques
- Cardiac Health and Mental Health
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Coronary Artery Anomalies
Deutsches Herzzentrum München
2019-2025
Technical University of Munich
2019-2025
München Klinik
2020
Heidelberg University
2018
The antiplatelet treatment strategy providing optimal balance between thrombotic and bleeding risks in patients undergoing coronary artery bypass grafting (CABG) is unclear. We prospectively compared the efficacy of ticagrelor aspirin after CABG.We randomly assigned double-blind fashion scheduled for CABG to either 90 mg twice daily or 100 (1:1) once daily. primary outcome was composite cardiovascular death, myocardial infarction (MI), repeat revascularization, stroke 12 months CABG. main...
Highlights•The analysis addresses the lack of age-related long-term data after PCI DES-ISR.•10-year clinical outcomes 3511 patients were analyzed.•Long-term rates adverse events and mortality DES-ISR are high.•Older show a twofold risk cardiac death compared with younger patients.•Long-term TLR rate is lower in older than patients.AbstractBackgroundOlder often underrepresented trials investigating treatment coronary drug-eluting stent (DES) restenosis, but outcome urgently needed an ageing...
The treatment of drug-eluting stent (DES) in-stent restenosis (ISR) is challenging as it has a high risk recurrence.
The aim of this two-center, all-comers registry was to compare the effectiveness and safety intravascular lithotripsy (IVL) that modified balloon angioplasty (MB). MB using a cutting or scoring is commonly used in patients with calcified coronary arteries. IVL new technology for lesion preparation. This first study IVL.
There are disparities in the adherence to guideline-recommended therapies after coronary artery bypass graft (CABG). We therefore sought evaluate effect of guideline-adherent medical secondary prevention on 1-year outcome CABG.Data were taken from randomized 'Ticagrelor CABG' trial. From April 2013 until 2017, patients who underwent CABG included. For present analysis, we compared treated with optimal those where 1 or more recommended medications missing.Follow-up data at 12 months available...
Abstract Background Only few data is available for long‐term outcomes of patients being treated in‐stent restenosis (ISR) in saphenous vein grafts (SVG). Aims Thus, the aim this observational, retrospective study was to close lack evidence. Methods Between January 2007 and February 2021 a total 163 with 186 ISR lesions located SVG were at two large‐volume centers Munich, Germany. Endpoints interest all‐cause mortality, target lesion revascularization (TLR) vessel myocardial infarction...
The performance of an everolimus-eluting bioresorbable scaffold (BRS) was inferior to metallic drug-eluting stent (DES) with permanent polymer, mainly due the mechanical features BRS technology. as compared DES polymers remains unstudied.